Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2018 FY- Text added to 2019 FY
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
AB, absorption, ACA, added, adding, addressing, adjacent, adjudication, Aerosphere, affirmed, ahead, airway, allergen, arose, attached, automation, Bank, banking, Boehringer, borrow, Breztri, British, buildout, burden, CCPA, CD, celiac, Chinese, Circuit, cloud, commentary, compliant, concept, concert, copromote, copy, corroborative, creditor, currency, customary, district, dollar, droxidopa, earmarked, economy, elevated, embolism, entirety, Euro, exert, exhaled, extra, FA, FeNO, fludrocortisone, flux, fractional, franchise, fumarate, gauge, glycopyrrolate, goodwill, hearing, hereto, Hong, Ingelheim, intangible, interaction, intra, irrespective, irreversible, JAKi, Kong, lab, landscape, levied, literature, Lonhala, Lundbeck, Macau, Magnair, magnitude, mediated, metabolized, midodrine, mild, NA, NaN, nitric, Northera, offshore, ophthalmic, ORIP, oxide, paydown, pharmacological, PhaRMASM, Pound, pre, precluding, rapidly, rational, reconsider, recruited, REDWOOD, regime, remanded, repay, repeat, resistant, rest, revisit, SAR, satisfaction, SEQUOIA, site, sixteen, Spiriva, SSF, steroid, stream, Taiwan, tangible, tenant, transportation, travel, trustee, UC, UK, unconstitutional, undermine, uptake
Removed:
accept, accrual, adequacy, adult, Alfa, Allergan, attributable, back, bacteria, bactericidal, batefenterol, beta, black, blood, branded, breakthrough, bronchodilator, cardiovascular, ceftaroline, cell, certify, characterize, circulation, Clinigen, Commissioner, comparator, compromised, congestive, consumed, contrast, creating, cyclic, dalbavancin, Dalvance, daptomycin, demonstrating, diabetic, EC, elimination, endoscopic, examined, executory, exhibited, expiratory, formulating, GMP, HABP, heart, highest, histologic, immune, inflow, Japanese, judgement, kidney, labor, linezolid, liquid, MAD, maladaptive, margin, maximal, Maximillian, medication, membrane, Merck, mg, microtracer, municipal, natriuretic, nebulizer, nephropathy, neprilysin, Orbactiv, oritavancin, packaged, penetration, pertaining, PHS, preliminary, prepaid, principally, protective, raw, realizable, realization, remodeling, renal, reversing, SAD, secondary, Sivextro, statistically, steady, stool, stringent, stronger, studied, superiority, sustained, symptom, tedizolid, Teflaro, telavancin, tissue, tofacitinib, Tokyo, trough, TSE, TURBOHALER, undertaken, unlabeled, VABP, vancomycin, vascular, ventilator, Wassermann
Valuein 2018 FY filing- Value in 2019 FY filing
Original filings
Filing view